Charity’s pharma investments raise questions around transparency and accountability

Albumin provides no benefit to hospitalized patients with advanced liver disease
3 March 2021
Covid-19, trust, and Wellcome: how charity’s pharma investments overlap with its research efforts
4 March 2021

Charity’s pharma investments raise questions around transparency and accountability

The Wellcome Trust, one of the world’s top funders of health research, stands to gain financially from the COVID-19 pandemic, raising questions about transparency and accountability, reports The BMJ today.

Comments are closed.